A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes

NCT06559722 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

510

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Insulin Degludec/liraglutide Injection
DRUG: XULTOPHY®

Sponsor

Tonghua Dongbao Pharmaceutical Co.,Ltd